+86(1812)4514114 [email protected]

SR9009 (1379686-30-2)

SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene……..


Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1240kg/month

Description

SR9009 (1379686-30-2) video

 

SR9009 (1379686-30-2) Description

SR-9009 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues.

It was shown to boost endurance, reduce anxiety, and decrease cholesterol, weight, and inflammation in mice. These effects, if proven in humans, would replicate some of the beneficial effects exercise has on our bodies and thus, improve our health. SR9009 side effects are still unknown. Read on to learn more about SR9009.

SR9009 (1379686-30-2) Specifications

Product Name SR9009
Chemical Name 1-Pyrrolidinecarboxylic acid, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-, ethyl ester
Brand Name No data available
Drug Class No data available
CAS Number 1379686-30-2
InChIKey MMJJNHOIVCGAAP-UHFFFAOYSA-N
Molecular Formula C20H24ClN3O4S
Molecular Weight 437.939 g/mol
Monoisotopic Mass 437.118 g/mol
Melting Point  No data available
Freezing Point No data available
Biological Half-Life No data available
Color Off-white powder
Solubility  Water Solubility : 0.00162 mg/mL
Storage Temperature  Store at room temperature
SR9009 Application boost endurance, reduce anxiety, and decrease cholesterol, weight, and inflammation in mice.

 


=

Reviews

There are no reviews yet.

Be the first to review “SR9009 (1379686-30-2)”

Your email address will not be published. Required fields are marked *

Shangke Chemical is a high-tech enterprise specializing in active pharmaceutical intermediates (APIs). To control the quality during production, a large number of experienced professionals, a first-class production equipment and laboratories are the key points.

Contact Us